Quick Answer
Crinetics Pharmaceuticals, Inc. reported Research And Development Expense of $332.06 million for the year ending 2025.
- Crinetics Pharmaceuticals, Inc. showed an increase of +38.3% in Research And Development Expense from 2024 to 2025.
- This data is from Crinetics Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Crinetics Pharmaceuticals, Inc.'s Research And Development Expense has grown by 6,410.9%.
- Historical annual values: Fiscal year 2025: $332.06 million | Fiscal year 2024: $240.16 million | Fiscal year 2023: $168.53 million | Fiscal year 2022: $130.23 million | Fiscal year 2021: $84.26 million | Fiscal year 2020: $57.00 million | Fiscal year 2019: $41.51 million | Fiscal year 2018: $24.48 million | Fiscal year 2017: $9.23 million | Fiscal year 2016: $5.10 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: